Opthea Ltd (OPT)
3.41
-0.17
(-4.75%)
USD |
NASDAQ |
May 17, 16:00
3.41
0.00 (0.00%)
After-Hours: 20:00
Opthea Enterprise Value: 139.54M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 139.54M |
May 15, 2024 | 139.54M |
May 14, 2024 | 142.02M |
May 13, 2024 | 146.99M |
May 10, 2024 | 142.85M |
May 09, 2024 | 157.76M |
May 08, 2024 | 115.50M |
May 07, 2024 | 119.24M |
May 06, 2024 | 128.20M |
May 03, 2024 | 126.12M |
May 02, 2024 | 118.00M |
May 01, 2024 | 115.10M |
April 30, 2024 | 119.65M |
April 29, 2024 | 113.85M |
April 26, 2024 | 124.62M |
April 25, 2024 | 143.68M |
April 24, 2024 | 127.11M |
April 23, 2024 | 121.31M |
April 22, 2024 | 122.97M |
April 19, 2024 | 116.34M |
April 18, 2024 | 124.62M |
April 17, 2024 | 124.62M |
April 16, 2024 | 136.22M |
April 15, 2024 | 137.88M |
April 12, 2024 | 157.76M |
Date | Value |
---|---|
April 11, 2024 | 166.05M |
April 10, 2024 | 166.88M |
April 09, 2024 | 178.48M |
April 08, 2024 | 153.62M |
April 05, 2024 | 174.33M |
April 04, 2024 | 166.05M |
April 03, 2024 | 170.19M |
April 02, 2024 | 170.19M |
April 01, 2024 | 185.93M |
March 28, 2024 | 183.45M |
March 27, 2024 | 166.88M |
March 26, 2024 | 150.31M |
March 25, 2024 | 149.48M |
March 22, 2024 | 156.11M |
March 21, 2024 | 131.25M |
March 20, 2024 | 129.60M |
March 19, 2024 | 123.80M |
March 18, 2024 | 123.80M |
March 15, 2024 | 128.77M |
March 14, 2024 | 132.91M |
March 13, 2024 | 120.48M |
March 12, 2024 | 118.82M |
March 11, 2024 | 123.80M |
March 08, 2024 | 118.82M |
March 07, 2024 | 120.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.12M
Minimum
Sep 22 2023
686.76M
Maximum
Sep 09 2019
251.59M
Average
221.60M
Median
Jun 09 2022
Enterprise Value Benchmarks
Kazia Therapeutics Ltd | 5.576M |
Immutep Ltd | -- |
Alterity Therapeutics Ltd | -- |
Mesoblast Ltd | -- |
Immuron Ltd | 1.912M |
Enterprise Value Related Metrics
Earnings Yield | -70.55% |
Normalized Earnings Yield | -69.68 |